SARS-CoV-1 therapeutic (Benevira)

N/A

Report date: 2025/03/20 15:59:52

Base Information

Drug NameSARS-CoV-1 therapeutic (Benevira)
Drug Alias NameSARS-CoV-1 therapeutic (Benevita)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBenevira Inc
China Registration ClassN/A

Develop Information

Active CompaniesBenevira Inc
Inactive CompaniesN/A
Active IndicationsSevere Acute Respiratory Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A